Patents by Inventor Marc Stadler
Marc Stadler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11959307Abstract: A magnetically-triggered lock mechanism for interengaging two relatively movable components. The lock mechanism includes a bolt mounted within a first component composed of a first material and displaceable between retracted and extended positions to interengage with a second component when the first and second components are in a predetermined position relative to each other and the bolt is extended, and a magnetically-releasable latch mechanism positioned to latch the bolt in a retracted position, the latch mechanism including a first magnet and mounted for movement between a biased latch engaging position and a latch releasing position. A support collar composed of a second material having higher strength than that of the first material is disposed around the bolt between an inner casing and outer casing of the first component and is spaced from the bolt to allow for sliding movement of the bolt through the support collar as the bolt moves between the extended and retracted positions.Type: GrantFiled: September 8, 2022Date of Patent: April 16, 2024Assignee: INTERLOCK USA, INC.Inventors: Peter J. Minter, Douglas Stadler, Marc Wesley Fullenwider, Anthony J. Frabbiele
-
Patent number: 11596150Abstract: The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m+n+o+p is not less than 14; and R is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen, and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof, as such or in the form of a composition, where the compound may be present in open chain form and/or in the form of a lactone (FIG. 1).Type: GrantFiled: January 31, 2020Date of Patent: March 7, 2023Assignee: IMD NATURAL SOLUTIONS GMBInventors: Marc Stadler, Jens Bitzer, Bärbel Köpcke, Kathrin Reinhardt, Jana Moldenhauer
-
Patent number: 11350628Abstract: The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m+n+o+p is not less than 14; and R is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen, and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof, as such or in the form of a composition, where the compound may be present in open chain form and/or in the form of a lactone (FIG. 1).Type: GrantFiled: June 8, 2021Date of Patent: June 7, 2022Assignee: IMD Natural Solutions GmbHInventors: Marc Stadler, Jens Bitzer, Bärbel Köpcke, Kathrin Reinhardt, Jana Moldenhauer
-
Publication number: 20210298303Abstract: The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m+n+o+p is not less than 14; and R is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen, and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof, as such or in the form of a composition, where the compound may be present in open chain form and/or in the form of a lactone (FIG. 1).Type: ApplicationFiled: June 8, 2021Publication date: September 30, 2021Applicant: IMD NATURAL SOLUTIONS GMBHInventors: Marc STADLER, Jens BITZER, Bärbel KÖPCKE, Kathrin REINHARDT, Jana MOLDENHAUER
-
Publication number: 20200154708Abstract: The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m+n+o+p is not less than 14; and R is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen, and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof, as such or in the form of a composition, where the compound may be present in open chain form and/or in the form of a lactone (FIG. 1).Type: ApplicationFiled: January 31, 2020Publication date: May 21, 2020Applicant: IMD NATURAL SOLUTIONS GMBHInventors: Marc STADLER, Jens BITZER, Bärbel KÖPCKE, Kathrin REINHARDT, Jana MOLDENHAUER
-
Patent number: 9453016Abstract: The invention relates to compositions and methods (with regard to animals and humans) for utilizing an extract and/or one or more natural spiro triterpenoids and derivatives thereof alone or as a supplement. Certain materials utilized are from the blazeispirol family, obtainable from Agaricus species. Treatments include the prophylactic and/or therapeutic treatment of a disease, disorder or condition that responds to the modulation of Liver X receptor, as well as corresponding methods of treatment, the manufacture of a pharmaceutical and nutraceutical formulation for said treatment. The invention also relates to the use of the extract and compound(s) in the treatment or in the preparation of a medicament (e.g. a nutraceutical) for the prophylactic and/or therapeutic treatments, as well as their preparation. It also relates to pharmaceutical or nutraceutical formulations described herein which are useful in prophylactic and therapeutic treatments. They can also be used for non-therapeutic, e.g.Type: GrantFiled: December 8, 2011Date of Patent: September 27, 2016Inventors: Torsten Grothe, Marc Stadler, Bärbel Köpcke, Ernst Roemer, Jens Bitzer, Philipp Wabnitz, Thomas Küper
-
Patent number: 9005939Abstract: The present invention relates to an isolated, recombinant or synthetic polynucleotide encoding a polypeptide with protoilludene synthase activity and comprising a sequence selected from the group consisting of a) SEQ ID Nos. 1 or 14 of the attached sequence listing; b) a nucleic acid sequence complementary to SEQ ID Nos. 1 or 14; c) nucleic acid sequences which hybridize under stringent conditions to the nucleic acid sequences defined in a) and b) or their complementary strands, as well as to the polypeptide encoded by the isolated polynucleotide, as well as a method for the production of melleolides employing the polynucleotide or polypeptide of the invention.Type: GrantFiled: January 31, 2013Date of Patent: April 14, 2015Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Inventors: Stefan Jennewein, Benedikt Engels, Torsten Grothe, Marc Stadler
-
Publication number: 20140178444Abstract: The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m+n+o+p is not less than 14; and R is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen, and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof, as such or in the form of a composition, where the compound may be present in open chain form and/or in the form of a lactone (FIG. 1).Type: ApplicationFiled: June 6, 2012Publication date: June 26, 2014Applicant: IMD NATURAL SOLUTIONS GMBHInventors: Marc Stadler, Jens Bitzer, Bärbel Köpcke, Kathrin Reinhardt, Jana Moldenhauer
-
Publication number: 20130338219Abstract: The invention relates to compositions and methods (with regard to animals and humans) for utilizing an extract and/or one or more natural spiro triterpenoids and derivatives thereof alone or as a supplement. Certain materials utilized are from the blazeispirol family, obtainable from Agaricus species. Treatments include the prophylactic and/or therapeutic treatment of a disease, disorder or condition that responds to the modulation of Liver X receptor, as well as corresponding methods of treatment, the manufacture of a pharmaceutical and nutraceutical formulation for said treatment. The invention also relates to the use of the extract and compound(s) in the treatment or in the preparation of a medicament (e.g. a nutraceutical) for the prophylactic and/or therapeutic treatments, as well as their preparation. It also relates to pharmaceutical or nutraceutical formulations described herein which are useful in prophylactic and therapeutic treatments. They can also be used for non-therapeutic, e.g.Type: ApplicationFiled: December 8, 2011Publication date: December 19, 2013Applicant: Intermed Discovery GMBHInventors: Torsten Grothe, Marc Stadler, Bärbel Köpcke, Ernst Roemer, Jens Bitzer, Philipp Wabnitz, Thomas Küper
-
Publication number: 20110015248Abstract: The present invention relates to substituted heterocycles, processes for their preparation, and their use in medicaments, especially for the treatment of inflammatory disease, i.e. asthma, or cancer.Type: ApplicationFiled: January 8, 2009Publication date: January 20, 2011Applicant: INTERMED DISCOVERY GMBHInventors: Marc STADLER, Stephan Seip, Hartwig Müller, Anke Mayer-Bartschmid, Michael-Alexander Brüning, Jordi Benet-Buchholz, Hiroko Togame, Reiko Dodo, Peter Reinemer, Kevin Bacon, Kinji Fuchikami, Satoko Matsukawa, Klaus Urbahns
-
Publication number: 20080064736Abstract: The use of a compound of formula (I) or a salt thereof, where the symbols have the meanings given in the description, for the control of phytopathogenic mircroorganisms of harmful animals.Type: ApplicationFiled: July 9, 2005Publication date: March 13, 2008Applicant: Bayer Cropscience AGInventors: Stefan Hillebrand, Oliver Guth, Welf-Burkhard Wiese, Klaus Kunz, Astrid Ullmann-Koppold, Amos Mattes, Peter Schreier, Ulrike Wachnedorff-Neumann, Karl-Heinz Kuck, Peter Losel, Olga Malsam, Peter Reinemer, Marc Stadler, Stefan Seip, Anke Mayer-Bartschmid, Hartwig Muller, Kevin Bacon, Mark Drewes, Kerstin Ilg
-
Publication number: 20060229353Abstract: The present invention relates to substituted heterocycles, processes for their preparation, and their use in medicaments, especially for the treatment of inflammatory disease, i.e. asthma, or cancer.Type: ApplicationFiled: February 6, 2004Publication date: October 12, 2006Inventors: Marc Stadler, Stephan Seip, Hartwig Müller, Anke Mayer-Bartschmid, Michael-Alexander Brüning, Jordi Benet-Buchholz, Hiroko Togame, Reiko Dodo, Peter Reinemer, Kevin Bacon, Kinji Fuchikami, Satoko Matsukawa, Klaus Urbahns
-
Publication number: 20040147766Abstract: The present invention relates to intermediates for preparing spinosyns, to a variety of processes for their preparation, and to the use of these intermediates for preparing spinosyn derivatives.Type: ApplicationFiled: March 3, 2004Publication date: July 29, 2004Inventors: Marc Stadler, Anke Mayer-Bartschmid, Stephan Seip, Robert Velten, Peter Jeschke, Karlheinz Weber